“We are really glad to welcome Katarzyna in our team of interdisciplinary experts”, says Claus Schaffrath, Managing Director of MD squared. ”She brings to the table a profound pedigree in Health Economics & Outcomes Research (HEOR). Katarzyna has shaped the understanding of pricing & reimbursement as critical factors for the market access and acceptance of Medical Devices In academia, in regional and global leadership positions in industry and as internationally recognized speaker.”
“I am very looking forward to work with my colleagues at MD squared, and helping its clients to make informed decisions in Health Economics”, says Katarzyna Kolasa, PhD. ”I am confident that my Market Access’s experience can help our customers to develop a successful value proposition for pricing & reimbursement discussion as well as local procurement efforts across different EU settings.”
Katarzyna Kolasa, PhD, is Professor of Health Economics at the Kozminski University in Warsaw and member of Health Sciences Policy Council (HSPC) at ISPOR’s (International Society for Health Economics and Outcomes Research). She is also currently chair elect of ISPOR Special Interest Group Digital Health.
With more than 20 years of academic and industry experience in the field of healthcare Katarzyna held regional and global leadership positions related to Health Economics and Market Access at AstraZeneca, BiogenIdec Bristol Myers Squibb, Lundbeck, Straub Medical and GE Healthcare.